End-of-day quote
Other stock markets
|
||
- USD | - |
03-28 | Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
03-28 | CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 16.2M 1.29B | Sales 2023 | 16M 1.28B | Capitalization | 5.47M 436M |
---|---|---|---|---|---|
Net income 2022 | -9M -719M | Net income 2023 | 3M 240M | EV / Sales 2022 | 0.36 x |
Net Debt 2022 | 917K 73.22M | Net cash position 2023 | 875K 69.86M | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-0.44
x | P/E ratio 2023 |
1.77
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
Latest transcript on CannaVEST Corp
Managers | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 15/06/14 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 25/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 15/06/14 |
Jamie Corroon
BRD | Director/Board Member | 54 | 20/07/22 |
William McCorkle
BRD | Director/Board Member | 56 | 20/10/22 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |